People
Gerd Hummel
Apollo Health Ventures current own career biography: Gerd supports Apollo and its portfolio as Venture Partner He has more than 20 years of experience in the pharma and biotech industry R&D and previously led R&D at Jerini AG and OryzonGenomics. Oryzon develops novel therapeutics based on epigenetics Gerd has a broad experience in the development of small molecules, peptides and peptidomimetics covering a wide range of therapeutic areas and therefore can provide highly valuable guidance in shaping R&D Before consulting international biotech companies, he received his PhD in organic chemistry from University of Konstanz Outside appointments are source-published career context; a manager/issuer board role is not a personal financing check.
Roles
Venture Partner